RE: Target price30 Nov 2021 15:55
The £8.5 million revenue was just for Q3 of course. From the 29th Sept RNS. "The company also provides an update on further strong trading in Q3 (revenues of at least £8.5m, adjusted EBITDA* of no less than £1.4m, and cash generative for the first time".
Since then a new rapid anti-gen testing service has been launched for travellers.
This company is just at the start of an amazing growth story.